120 related articles for article (PubMed ID: 15064931)
1. A qualitative study of head and neck cancer.
Moore RJ; Chamberlain RM; Khuri FR
Support Care Cancer; 2004 May; 12(5):338-46. PubMed ID: 15064931
[TBL] [Abstract][Full Text] [Related]
2. Communicating suffering in primary stage head and neck cancer.
Moore RJ; Chamberlain RM; Khuri FR
Eur J Cancer Care (Engl); 2004 Mar; 13(1):53-64. PubMed ID: 14961776
[TBL] [Abstract][Full Text] [Related]
3. Connexin expression and gap junctional intercellular communication in human squamous cell carcinoma of the head and neck.
Frank DK; Szymkowiak B; Hughes CA
Otolaryngol Head Neck Surg; 2006 Nov; 135(5):736-43. PubMed ID: 17071304
[TBL] [Abstract][Full Text] [Related]
4. The economics of squamous cell carcinoma of the head and neck.
Menzin J; Lines LM; Manning LN
Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):68-73. PubMed ID: 17413405
[TBL] [Abstract][Full Text] [Related]
5. Individualised quality of life as a measure to guide treatment choices in squamous cell carcinoma of the head and neck.
Licitra L; MesÃa R; Keilholz U
Oral Oncol; 2016 Jan; 52():18-23. PubMed ID: 26578389
[TBL] [Abstract][Full Text] [Related]
6. A blessing and a curse: head and neck cancer survivors' experiences.
Swore Fletcher B; Cohen MZ; Schumacher K; Lydiatt W
Cancer Nurs; 2012; 35(2):126-32. PubMed ID: 21760486
[TBL] [Abstract][Full Text] [Related]
7. Survivorship and Quality of Life in Head and Neck Cancer.
Ringash J
J Clin Oncol; 2015 Oct; 33(29):3322-7. PubMed ID: 26351336
[TBL] [Abstract][Full Text] [Related]
8. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
[TBL] [Abstract][Full Text] [Related]
9. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
Bas M; Bier H; Schirlau K; Friebe-Hoffmann U; Scheckenbach K; Balz V; Whiteside TL; Hoffmann TK
Oral Oncol; 2006 Aug; 42(7):691-7. PubMed ID: 16527515
[TBL] [Abstract][Full Text] [Related]
10. Communication changes following non-glottic head and neck cancer management: The perspectives of survivors and carers.
Nund RL; Rumbach AF; Debattista BC; Goodrow MN; Johnson KA; Tupling LN; Scarinci NA; Cartmill B; Ward EC; Porceddu SV
Int J Speech Lang Pathol; 2015 Jun; 17(3):263-72. PubMed ID: 25764915
[TBL] [Abstract][Full Text] [Related]
11. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
[TBL] [Abstract][Full Text] [Related]
12. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
[TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary approach to cancer treatment: focus on head and neck cancer.
Haddad R; Annino D; Tishler RB
Dent Clin North Am; 2008 Jan; 52(1):1-17, vii. PubMed ID: 18154862
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
[TBL] [Abstract][Full Text] [Related]
15. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data.
Lang K; Menzin J; Earle CC; Jacobson J; Hsu MA
Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1269-75. PubMed ID: 15545580
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.
Kawakami M; Kawakami K; Kasperbauer JL; Hinkley LL; Tsukuda M; Strome SE; Puri RK
Clin Cancer Res; 2003 Dec; 9(17):6381-8. PubMed ID: 14695138
[TBL] [Abstract][Full Text] [Related]
17. The experience of food, eating and meals following radiotherapy for head and neck cancer: a qualitative study.
Ottosson S; Laurell G; Olsson C
J Clin Nurs; 2013 Apr; 22(7-8):1034-43. PubMed ID: 23480499
[TBL] [Abstract][Full Text] [Related]
18. Narrow band imaging for detecting superficial squamous cell carcinoma of the head and neck in patients with esophageal squamous cell carcinoma.
Katada C; Tanabe S; Koizumi W; Higuchi K; Sasaki T; Azuma M; Katada N; Masaki T; Nakayama M; Okamoto M; Muto M
Endoscopy; 2010 Mar; 42(3):185-90. PubMed ID: 20195988
[TBL] [Abstract][Full Text] [Related]
19. Physical activity and quality of life in head and neck cancer survivors.
Rogers LQ; Courneya KS; Robbins KT; Malone J; Seiz A; Koch L; Rao K; Nagarkar M
Support Care Cancer; 2006 Oct; 14(10):1012-9. PubMed ID: 16538497
[TBL] [Abstract][Full Text] [Related]
20. Head and neck squamous cell carcinomas.
Fayette J
Anticancer Drugs; 2011 Aug; 22(7):585. PubMed ID: 21705866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
